PROTECTING PRODUCTIVITY WITH QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN THE UK

被引：1
|
作者：
Gregg, M. [1 ]
Meier, G. [1 ]
机构：
[1] GlaxoSmithKline Vaccines, Wavre, Belgium
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2497
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN56
引用
收藏
页码：A673 / A673
页数：1
相关论文
共 50 条
  • [1] Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
    Gresset-Bourgeois, Viviane
    Leventhal, Phillip S.
    Pepin, Stephanie
    Hollingsworth, Rosalind
    Kazek-Duret, Marie-Pierre
    De Bruijn, Iris
    Samson, Sandrine I.
    EXPERT REVIEW OF VACCINES, 2018, 17 (01) : 1 - 11
  • [2] Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults
    Pepin, Stephanie
    Donazzolo, Yves
    Jambrecina, Alen
    Salamand, Camille
    Saville, Melanie
    VACCINE, 2013, 31 (47) : 5572 - 5578
  • [3] Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study
    Airey, Jolanta
    Albano, Frank R.
    Sawlwin, Daphne C.
    Jones, Alison Graves
    Formica, Neil
    Matassa, Vince
    Leong, Jane
    VACCINE, 2017, 35 (20) : 2745 - 2752
  • [4] Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults
    Greenberg, David P.
    Robertson, Corwin A.
    Noss, Michael J.
    Blatter, Mark M.
    Biedenbender, Rex
    Decker, Michael D.
    VACCINE, 2013, 31 (05) : 770 - 776
  • [5] Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study
    Hsiao, Amber
    Hansen, John
    Nunley, Karen Valdez
    Lewis, Ned
    Selmani, Alex
    Inamdar, Ajinkya
    Mallett-Moore, Tamala
    Izikson, Ruvim
    Rudin, Deborah
    Klein, Nicola P.
    VACCINE, 2022, 40 (05) : 774 - 779
  • [6] High-Dose Inactivated Influenza Vaccine Quadrivalent for Older Adults
    Chahine, Elias B.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (01) : 89 - 97
  • [7] Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
    Yvette N. Lamb
    Drugs, 2019, 79 : 1337 - 1348
  • [8] Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
    Lamb, Yvette N.
    DRUGS, 2019, 79 (12) : 1337 - 1348
  • [9] Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
    Rodrigo Luiz Carregaro
    Alessandra N. C. P. Roscani
    Augusto Cesar Sousa Raimundo
    Larissa Ferreira
    Tazio Vanni
    Maria da Graça Salomão
    Livia Fernandes Probst
    Juliana Yukari K. Viscondi
    BMC Infectious Diseases, 23
  • [10] Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
    Carregaro, Rodrigo Luiz
    Roscani, Alessandra N. C. P.
    Raimundo, Augusto Cesar Sousa
    Ferreira, Larissa
    Vanni, Tazio
    Salomao, Maria da Graca
    Probst, Livia Fernandes
    Viscondi, Juliana Yukari K.
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
12345